161 related articles for article (PubMed ID: 26354850)
1. GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy.
Deng X; Yang X; Cheng Y; Liu X; Li X; Zhao R; Qin C; Lu Q; Yin C
Sci Rep; 2015 Sep; 5():14000. PubMed ID: 26354850
[TBL] [Abstract][Full Text] [Related]
2. XRCC1 polymorphisms associated with survival among Chinese bladder cancer patients receiving epirubicin and mitomycin C.
Deng X; Zhang X; Cheng Y; Yang X; Zhao R; Liu X; Li X; Qin C; Lu Q; Yin C
Tumour Biol; 2015 Jun; 36(6):4591-6. PubMed ID: 25616696
[TBL] [Abstract][Full Text] [Related]
3. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic association between GSTP1 genetic polymorphism and febrile neutropenia in Japanese patients with early breast cancer.
Sugishita M; Imai T; Kikumori T; Mitsuma A; Shimokata T; Shibata T; Morita S; Inada-Inoue M; Sawaki M; Hasegawa Y; Ando Y
Breast Cancer; 2016 Mar; 23(2):195-201. PubMed ID: 25008867
[TBL] [Abstract][Full Text] [Related]
5. Glutathione S-transferase T1, O1 and O2 polymorphisms are associated with survival in muscle invasive bladder cancer patients.
Djukic TI; Savic-Radojevic AR; Pekmezovic TD; Matic MG; Pljesa-Ercegovac MS; Coric VM; Radic TM; Suvakov SR; Krivic BN; Dragicevic DP; Simic TP
PLoS One; 2013; 8(9):e74724. PubMed ID: 24040330
[TBL] [Abstract][Full Text] [Related]
6. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer.
Xu Z; Zhu H; Luk JM; Wu D; Gu D; Gong W; Tan Y; Zhou J; Tang J; Zhang Z; Wang M; Chen J
Cancer; 2012 Nov; 118(22):5489-96. PubMed ID: 22517484
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase polymorphisms influence chemotherapy response and treatment outcome in breast cancer.
Wang J; Wang T; Yin GY; Yang L; Wang ZG; Bu XB
Genet Mol Res; 2015 Sep; 14(3):11126-32. PubMed ID: 26400343
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy.
Geng R; Chen Z; Zhao X; Qiu L; Liu X; Liu R; Guo W; He G; Li J; Zhu X
PLoS One; 2014; 9(12):e116027. PubMed ID: 25545243
[TBL] [Abstract][Full Text] [Related]
10. Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer.
Booton R; Ward T; Heighway J; Ashcroft L; Morris J; Thatcher N
J Thorac Oncol; 2006 Sep; 1(7):679-83. PubMed ID: 17409936
[TBL] [Abstract][Full Text] [Related]
11. Transformation of alkylating regimen of thiotepa into tepa determines the disease progression through GSTP1 gene polymorphism for metastatic breast cancer patients receiving thiotepa containing salvage chemotherapy.
Zhou X; Wang X; Song Q; Yang H; Zhu X; Yu J; Song G; Di L; Ren J; Shao H; Lyerly HK
Int J Clin Pharmacol Ther; 2015 Nov; 53(11):914-22. PubMed ID: 26396136
[TBL] [Abstract][Full Text] [Related]
12. Predictive potential of ABCB1, ABCC3, and GSTP1 gene polymorphisms on osteosarcoma survival after chemotherapy.
Liu S; Yi Z; Ling M; Shi J; Qiu Y; Yang S
Tumour Biol; 2014 Oct; 35(10):9897-904. PubMed ID: 24996541
[TBL] [Abstract][Full Text] [Related]
13. Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology.
Kraggerud SM; Oldenburg J; Alnaes GI; Berg M; Kristensen VN; Fossa SD; Lothe RA
Pharmacogenet Genomics; 2009 Oct; 19(10):751-9. PubMed ID: 19741569
[TBL] [Abstract][Full Text] [Related]
14. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcomes of patients with advanced non-small cell lung cancer.
Liu JY; Liu QM; Li LR
Genet Mol Res; 2015 Aug; 14(3):10331-7. PubMed ID: 26345972
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.
Funke S; Timofeeva M; Risch A; Hoffmeister M; Stegmaier C; Seiler CM; Brenner H; Chang-Claude J
Pharmacogenomics; 2010 Jan; 11(1):33-41. PubMed ID: 20017670
[TBL] [Abstract][Full Text] [Related]
16. Predictive potential role of glutathione S-transferase polymorphisms in the prognosis of breast cancer.
Wang X; Huang ZH
Genet Mol Res; 2015 Aug; 14(3):10236-41. PubMed ID: 26345960
[TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-Transferase Pi 1 (GSTP1) Gene 313 A/G (rs1695) polymorphism is associated with the risk of urinary bladder cancer: Evidence from a systematic review and meta-analysis based on 34 case-control studies.
Song Y; Chen J; Liu K; Zhou K; Lu Y; Wang X; Yang Y; Liu X
Gene; 2019 Nov; 719():144077. PubMed ID: 31454540
[TBL] [Abstract][Full Text] [Related]
19. Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients.
Chen L; Qi H; Zhang L; Li H; Shao J; Chen H; Zhong M; Shi X; Ye T; Li Q
BMC Cancer; 2018 Oct; 18(1):1038. PubMed ID: 30359238
[TBL] [Abstract][Full Text] [Related]
20. Role of glutathione S-transferases in melanoma susceptibility: association with GSTP1 rs1695 polymorphism.
Ibarrola-Villava M; Martin-Gonzalez M; Lazaro P; Pizarro A; Lluch A; Ribas G
Br J Dermatol; 2012 Jun; 166(6):1176-83. PubMed ID: 22251241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
